The company

obvioTec AG is a Swiss technology company. Our unique and disruptive technology significantly improves pharma quality control, accelerates control and release processes and reduces cost. As a result, the number of recalls can be reduced and drug- and patient safety is improved. We offer managed "technology as a service".

Our history

idea was born to use terahertz technology for real world applications e.g. authenticity testing of pharmaceutical medicines

incorporation of TERA Group, four founders, HQ Zurich-Zollikon, first market activities & technology experiments

seed money round, proof of concept with technology partners, raising market interest

team extention, move into new lab facility in Hombrechtikon/ZH, test-systems built, acceleration of technical and marketing activities

first contracts signed with global pharma and diagnostics companies

financing company growth and extending market position.

TERA Group AG is now obvioTec AG

FAT passed with an MVP for consumables testing (global diagnostics company)

obvioTec AG | Alte Landstrasse 74 | P.O.Box 219 | 8702 Zollikon-Zurich | Switzerland

044 515 55 33 | welcome@obviotec.com | www.obviotec.com |

This presentation does not constitute as a prospectus in the legal sense. All information about the current situation and the planned proceedings are made in good faith and to the best of our knowledge. Forecasts about the future business development and forward-looking financial models are based on assumptions and are dependent on external circumstances and developments on which the company has no direct influence. Therefore all information is without guarantee. obvioTec AG, September 2021

Matrix themes